glp-1 drug liraglutide may protect against dementia Ozempic predecessor suggests potential for drugs in Alzheimer's in early trial How GLP-1s Could Transform Alzheimer's

These effects were attributed to the sustained increases in GH and IGF-1 produced by the peptide

Because the milligram amount is fixed, a lighter body gets more drug exposure per pound: roughly 22% more at 70 kg and about a third less at 120 kg, compared with a 90 kg reference. The dose still comes from response and tolerability, but a lighter person is running a hotter exposure at the same number on the vial

However, if you experience new or worsening neurological symptoms, or if theyre accompanied by other symptoms listed here, contact your doctor immediately

Points were awarded to OBS for comparability if they controlled or adjusted for age and concomitant medications because both are considered important risk factors for HZ [1, 8]